Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 9;12(6):809.
doi: 10.3390/biom12060809.

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies

Giuseppe Mandraffino  1 , Alessandro Mattina  2 , Roberto Scicali  3
Affiliations
Editorial

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies

Giuseppe Mandraffino et al. Biomolecules. .

Abstract

Atherosclerosis is a long-term damaging process, and its progression leads to cardiovascular system injury [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Jebari-Benslaiman S., Galicia-García U., Larrea-Sebal A., Olaetxea J.R., Alloza I., Vandenbroeck K., Benito-Vicente A., Martín C. Pathophysiology of Atherosclerosis. Int. J. Mol. Sci. 2022;23:3346. doi: 10.3390/ijms23063346. - DOI - PMC - PubMed
    1. Björkegren J.L.M., Lusis A.J. Atherosclerosis: Recent developments. Cell. 2022;185:1630–1645. doi: 10.1016/j.cell.2022.04.004. - DOI - PMC - PubMed
    1. Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. doi: 10.1016/j.atherosclerosis.2019.08.014. - DOI - PubMed
    1. Rehues P., Rodríguez M., Álvarez J., Jiménez M., Melià A., Sempere M., Balsells C., Castillejo G., Guardiola M., Castro A., et al. Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men. Biomolecules. 2022;12:47. doi: 10.3390/biom12010047. - DOI - PMC - PubMed
    1. Manjarrez-Reyna A.N., Martínez-Reyes C.P., Aguayo-Guerrero J.A., Méndez-García L.A., Esquivel-Velázquez M., León-Cabrera S., Vargas-Alarcón G., Fragoso J.M., Carreón-Torres E., Pérez-Méndez O., et al. Native Low-Density Lipoproteins Act in Synergy with Lipopolysaccharide to Alter the Balance of Human Monocyte Subsets and Their Ability to Produce IL-1 Beta, CCR2, and CX3CR1 In Vitro and In Vivo: Implications in Atherogenesis. Biomolecules. 2021;11:1169. doi: 10.3390/biom11081169. - DOI - PMC - PubMed

Publication types